SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022393
Filing Date
2020-05-07
Accepted
2020-05-07 08:12:27
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imra-10q_20200331.htm 10-Q 2019195
2 EX-31.1 imra-ex311_9.htm EX-31.1 19380
3 EX-31.2 imra-ex312_8.htm EX-31.2 19618
4 EX-32.1 imra-ex321_6.htm EX-32.1 9842
5 EX-32.2 imra-ex322_7.htm EX-32.2 10043
  Complete submission text file 0001564590-20-022393.txt   6086534

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imra-20200331.xml EX-101.INS 1081986
7 XBRL TAXONOMY EXTENSION SCHEMA imra-20200331.xsd EX-101.SCH 45933
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imra-20200331_cal.xml EX-101.CAL 36781
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imra-20200331_def.xml EX-101.DEF 150976
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20200331_lab.xml EX-101.LAB 355510
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20200331_pre.xml EX-101.PRE 296978
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39247 | Film No.: 20854673
SIC: 2834 Pharmaceutical Preparations